Compugen Ltd.
CGEN
$1.90
-$0.01-0.52%
Headlines
4/25/2024
-
PR Newswire
4/23/2024
-
Zolmax
4/18/2024
-
Zolmax
4/13/2024
-
Ticker Report
4/13/2024
-
Zolmax
4/10/2024
-
The Fly
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
4/10/2024
-
PR Newswire
4/5/2024
-
Simply Wall St
4/3/2024
-
PR Newswire
3/19/2024
-
Ticker Report
3/12/2024
-
Zacks Investment Research
3/11/2024
-
PR Newswire
3/8/2024
-
Simply Wall St
3/8/2024
-
Zolmax
3/7/2024
-
GuruFocus
3/7/2024
-
Insider Monkey
3/6/2024
-
PR Newswire
3/5/2024
-
Seeking Alpha: Transcripts
3/5/2024
-
SeekingAlpha
3/5/2024
-
Seeking Alpha - Israel Stocks
3/5/2024
-
InvestorPlace
3/5/2024
-
The Fly
3/5/2024
-
Seeking Alpha - Israel Stocks
3/5/2024
-
PR Newswire
Income Statement
--
--
--
--
Cash Flow
--
--
--
--
Filings
Tuesday, March 5, 2024
Sunday, December 31, 2023
Week of May 13 and 17 (est)
Price History
Corporate Info
972 3 765 8585
Azrieli Center
Building D - 26 Harokmim Street
Holon, 5885849
Building D - 26 Harokmim Street
Holon, 5885849
Business Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and...
more